-+*HIV pre-exposure prophylaxis (PrEP) is the use of daily antiretroviral medications by HIV-negative individuals to reduce their risk of HIV infection. PrEP is a highly effective HIV-risk reduction strategy and a critical part of a comprehensive approach to HIV prevention. To improve access to PrEP, it is important to monitor PrEP uptake. However, Ontario does […]
HIV pre-exposure prophylaxis (PrEP) in Ontario, 2020 Read More »
-+*td {vertical-align:top !important; padding: 20px !important;} Download pdf Questions What is the current evidence among women in high-income countries regarding HIV risk after acquiring a sexually transmitted infection (STI)? What does the evidence state regarding the use of pre-exposure prophylaxis (PrEP) to prevent HIV among women who have acquired an STI? Key take-home messages A
-+*The Ontario HIV Treatment Network (OHTN) is pleased to announce the release of a new report titled “HIV pre-exposure prophylaxis in Ontario”. View (or Download) Report HIV pre-exposure prophylaxis (PrEP) is a highly effective HIV-risk reduction strategy, but little is known about PrEP uptake in Ontario. This report uses dispensations from pharmacies from July 2015
HIV pre-exposure prophylaxis (PrEP) use in Ontario, 2015-2018 Report Read More »
-+*Andrew Grulich, Professor and Program Head HIV Epidemiology and Prevention Program, Kirby Institute, UNSW Sydney, Australia Targeted Rapid PrEP: Impact & Lessons Learned New South Wales was the first state in Australia to trial PrEP at a large scale. The high-level, targeted, rapid roll-out of PrEP led to a 25% decline in state-wide HIV diagnoses
Andrew Grulich : Targeted rapid PrEP : Impact & Lessons Learned Read More »
